BMRN FY 2021 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.8B-0.8% YoY

Gross Profit

$1.4B74.5% margin

Operating Income

-$82M-4.5% margin

Net Income

-$64M-3.5% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

$305M

Free Cash Flow

$185M

Stock-Based Comp.

$197M

Balance Sheet

Total Assets

$6.0B

Total Liabilities

$1.7B

Stockholders' Equity

$4.3B

Cash & Equivalents

$587M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.9B	-0.8%
Gross Profit	$1.4B	$1.3B	+3.0%
Operating Income	-$82M	-$43M	-89.6%
Net Income	-$64M	$854M	-107.5%